Table 2.
Relationships between the miRNA signature scores and clinical characteristics in CRC patients.
| Variable | Number | miRNA Score | p-valuea |
|---|---|---|---|
| Age | |||
| <60 | 89 | 0.60 ± 0.27 | 0.070 |
| ≧60 | 134 | 0.55 ± 0.24 | |
| Gender | |||
| Female | 99 | 0.58 ± 0.27 | 0.436 |
| Male | 124 | 0.56 ± 0.24 | |
| Tumor stage | |||
| Early (0, I & II) | 124 | 0.53 ± 0.26 | 0.016 |
| Late (III & IV) | 96 | 0.62 ± 0.24 | |
| Tumor location | |||
| Right | 68 | 0.44 ± 0.23 | <0.001 |
| Left | 146 | 0.63 ± 0.24 | |
| Tumor size | |||
| <4 cm | 119 | 0.53 ± 0.25 | 0.005 |
| ≧4 cm | 100 | 0.62 ± 0.25 | |
| Recurrence | |||
| No | 165 | 0.54 ± 0.26 | 0.024 |
| Yes | 42 | 0.65 ± 0.23 | |
Mann-Whitney U test.